Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Bloodstream InfectionsShort Bowel SyndromeDevelopmentNutritionBiological Markers
Interventions
DRUG

Glutamine

0.3 g/kg, taken orally/feeding tube every 12 hours/twice a day for 180 days (6 months)

DIETARY_SUPPLEMENT

L-alanine

0.3 g/kg, taken orally/feeding tube every 12 hours/twice a day for 180 day (6 months)

Trial Locations (2)

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

48109

C.S. Mott Children's Hosptial, Ann Arbor

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

Emmaus Medical, Inc.

INDUSTRY

collaborator

University of Michigan

OTHER

collaborator

Emory University

OTHER

collaborator

University of Colorado, Denver

OTHER

lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT01576003 - Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants | Biotech Hunter | Biotech Hunter